Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Tax Rate of 17.68% for Q1 2026, up 616.0% year-over-year from 2.47% in Q1 2025, and up 68.2% on a QoQ basis from 10.51% in Q4 2025.
Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals (VRTX) has reported Tax Rate for 16 consecutive years, with 17.68% the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Rate rose 616.0% year-over-year to 17.68%; the TTM figure through Mar 2026 stood at 16.02% (up 24543.0% YoY), while the FY2025 annual figure was 14.86%, down 30067.0% from the prior year.
- Tax Rate came in at 17.68% for Q1 2026 at Vertex Pharmaceuticals, up from 10.51% in the prior quarter.
- The five-year high for Tax Rate was 23.95% in Q4 2022, with the low at 5.97% in Q2 2024.
- Average Tax Rate over 5 years is 16.15%, with a median of 17.68% recorded in 2026.
- Across the five-year window, Tax Rate slumped 23070 bps in 2022 and surged 2546 bps in 2025, its largest moves.
- Year by year, Tax Rate stood at 23.95% in 2022, then tumbled by 35 bps to 15.58% in 2023, then increased by 26 bps to 19.67% in 2024, then slumped by 47 bps to 10.51% in 2025, then jumped by 68 bps to 17.68% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 17.68%, 10.51%, and 16.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 5.61% |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 12.29% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 17.68% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 9.35% |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 12.51% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 13.70% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 7.07% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -0.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.68% |
| Mar 31, 2026 | 17.68% |
| Dec 31, 2025 | 10.51% |
| Dec 31, 2025 | 10.51% |
| Sep 30, 2025 | 16.62% |
| Sep 30, 2025 | 16.62% |
| Jun 30, 2025 | 19.49% |
| Jun 30, 2025 | 19.49% |
| Mar 31, 2025 | 11.51% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | 19.67% |
| Dec 31, 2024 | 19.67% |
| Sep 30, 2024 | 14.60% |
| Sep 30, 2024 | 14.60% |
| Jun 30, 2024 | -5.97% |
| Jun 30, 2024 | -5.97% |
| Mar 31, 2024 | 14.03% |
| Mar 31, 2024 | 14.03% |
| Dec 31, 2023 | 15.58% |
| Dec 31, 2023 | 15.58% |